In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Carlton Weatherby, vice president and general manager of Spine and Biologics at Medtronic. He provides insight on why the organization acquired Mazor and Titan Spine, the strategy for the division to address more of the care continuum, and how trends are being addressed such as AI, data, and MIS. Specifically, the following questions are addressed.

• Medtronic has made two interesting acquisitions in the Spine space. Can you tell us what made Mazor and Titan Spine attractive targets?
• Medtronic has demonstrated an interest in providing a solution for the entire care chain in other therapy areas, such as in diabetes. Is Spine headed in a similar direction?
• As you know, minimally invasive in spine is the trend. How is Medtronic addressing this?
• Another significant trend in medtech is the incorporation of data and artificial intelligence. What is Medtronic doing in these areas with regard to spine?
• What’s ahead? What can you share with regard to Medtronic’s spine future?

Listen to this episode and see what you think of Medtronic’s approach to spine. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at [email protected].

Send us a text

For more medtech news and information, visit www.mpomag.com.